ORION CORPORATION
STOCK EXCHANGE RELEASE
The share acquisitions announced by
After the repurchases, the Company holds a total of 932,771 own B shares corresponding to approximately 0.66% of the total number of the shares and 0.12% of the votes.
President and CEO | SVP, Corporate Functions |
Contact person:
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
https://www.orion.fi/en
https://www.twitter.com/OrionCorpIR
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion’s pharmaceutical R&D are oncology and pain. Orion’s net sales in 2021 amounted to
© OMX, source